Trial Information
Summary: A Randomized, Multicenter, Double-blind, Placebo-controlled, Dose-range-finding, Parallel-design, Phase 2 Trial of Oral Linaclotide Acetate Administered to Patients with Irritable Bowel Syndrome with Constipation
ATTENTION: Men & Women
Do You Have Pain in Your Belly?
Do you have Chronic Abdominal Pain or Discomfort with
Constipation?
If so, you may have a medical condition known as Irritable Bowel
Syndrome with Constipation or IBS-C.
We are looking for men and women with IBS-C to participate in a
clinical research study of an investigational medication for the
treatment of the symptoms of IBS-C.
You may qualify for the study if you meet the following
criteria:
- Are at least 18 years of age;
- Have abdominal discomfort or pain and fewer than 3 bowel
movements per week, with a feeling of incomplete evacuation;
- Have hard or lumpy stools or straining during a bowel
movement;
- Speak English fluently;
- Are able to complete a daily phone questionnaire during study
participation.
If you qualify to participate in this study, you will receive
study medication, office visits, and study related medical
procedures at no cost.
If you are interested in receiving more information, or to see
if you qualify,
|
Contact:
Carolinas Research Associates
4808 Pellyn Farm Ct.
Charlotte, NC 28226
Telephone: 704-366-3001
Email:
|
|

If you would like to learn more about participating in this study, please send an e-mail message using the form below.
Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.
This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.
Trial listings updated: June 1, 2008 at 6:31:30 AM